EBRCZ · EBR Systems, Inc.
$0.11
At close · Oct 15
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's cash, cash equivalents, and marketable securities as of June 30, 2026, and its expectation to generate operating losses and negative operating cash flows in the foreseeable future, as well as potential liquidity to become less than the $2.5 million required under its existing debt covenants during the next twelve months, there exists substantial doubt regarding the Company's ability to continue as a going concern for a period of at least twelve months from the date of issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 11, 2026
Market Cap
$8.64M
Shares
75.34M
Volume · Oct 15
1000
Avg daily vol (3M)
15.75K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.11
Open$0.11
Day$0.11–0.11
52W close$0.11–1.20
Avg vol 30d17K
Short int15K · 0.0% float · 2.2d
Short vol87%
DataNov 2022–Oct 2026
Filing10-Q · Aug 11
Up next
filed Aug 11, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$6.45M
Trailing 12 months
Net income (TTM)
−$60.76M
Trailing 12 months
Revenue growth YoY
+1,451.2%
Year over year
Operating margin
-2,850.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-861.5%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$44.14M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+24.4%
Year over year · more shares
Price change (1Y)
-87.9%
Trailing year
Short interest
—
Latest settlement
Quarterly results
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.7 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−63%
below
RSI (14)
32
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−55%
trailing
YTD return
−90%
this year
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.02% of float · ▼ -90.3% MoM · 2.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Gross margin
30%
EPS growth
+8%
Y/Y
Free cash flow
$-56.9M
Balance sheet
$36.0M
net debt
Quant / Vol
risk profile
Volatility
270%
annualized · 1-yr
Max drawdown
−90%
past year
ATR
28.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−63%
Bearish
RSI (14)
32
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.02% of float · ▼ -90.3% MoM · 2.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $1
vs 50-day avg -63%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| commercial implants | 46 | the three months ended June 30, 2026 filing | — |
| Gross margin (excluding the use of previously expensed inventory) non-GAAP | 16.9% | the three months ended June 30, 2026 filing | — |
| hospitals with commercial implants | 23 | the three months ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EBRCZ
this stock
EBR Systems, Inc.
|
$8.64M | -90.4% | — | — | 0.0% |
|
ABT
Abbott Laboratories
|
$171.24B | -19.8% | +5.7% | 31.8 | 0.8% |
|
MDT
Medtronic plc
|
$121.04B | -3.2% | +8.4% | 23.3 | 3.1% |
|
SYK
Stryker Corp
|
$116.76B | -15.3% | +11.2% | 31.5 | 1.5% |
|
BSX
Boston Scientific Corp
|
$64.51B | -53.3% | +12.5% | 18.0 | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EBRCZ | -49.1% | -55.1% | — | -49.1% | -90.4% |
| SPY | -0.3% | +1.2% | +8.1% | +1.2% | +13.2% |
| vs SPY | -48.8% | -56.3% | — | -50.3% | -103.5% |